Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vascularized nerve grafts: an experimental study.
A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Induction of gut regulatory CD39(+) T cells by teriflunomide protects against EAE.
Peculiarities of Neurological Disorders and Study Designs.
Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.
Measurement properties of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ): a study based on Classical Test Theory.
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Distinctive characteristics of early-onset and late-onset neuromyelitis optica spectrum disorders.
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis.
Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation.
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
[Multiple Sclerosis and Commensal Gut Flora].
Regional differences in interhemispheric structural fibers in healthy, term infants.
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
The progeroid gene BubR1 regulates axon myelination and motor function.
Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
The relationship between sleep quality and perceived fatigue measured using the Neurological Fatigue Index in people with Multiple Sclerosis.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
An In Vitro Diagnostic for Multiple Sclerosis Based on C-peptide Binding to Erythrocytes.
What is the future of proof of concept studies in multiple sclerosis?
Immunological processes related to cognitive impairment in MS.

Pages